SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 ...

The spike protein of the coronavirus, or SARS-CoV-2, binds to ACE2, a receptor on the host cells, which allows the virus to enter the cells and infect it. Binding is the first step for infection, and ...

The key player in SARS-CoV-2's infection process is the receptor binding domain (RBD) of the spike protein. The RBD determines how well the virus binds to ACE2, the human cellular receptor ...

Two weeks ago, a blogger wrote about a Yale School of Medicine study that he alleged proved that millions of long COVID sufferers might, in fact, have been injured by the vaccine. The story blew up on ...

"The 'key' is the viral spike protein and the 'lock' is the cell's ACE2 receptor. The 'teeth' on the key are the spike amino ...

Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

The spike protein of the new coronavirus infected human cells that had high levels of the ACE2 receptor in test tubes, as well as in small models of human airways and intestines. The researchers ...

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could ...